Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Essler

Showing results (71-80 of 208) with videos related to

Pageof 21
Sort By:
The Prostate|March 20, 2024
Key learnings from concordant systematic biopsies in prostate-specific membrane antigen positron emission tomography/computed tomography-guided prostate biopsies: Enhancing targeting accuracyThomas Büttner, Florian Gärtner, Markus Essler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
Preclinical evaluation of the alpha-particle generator nuclide 225Ac for somatostatin receptor radiotherapy of neuroendocrine tumorsMatthias Miederer, Gjermund Henriksen, Andrea Alke, et al.
Oncotarget|October 4, 2018
Role of textural heterogeneity parameters in patient selection for 177Lu-PSMA therapy via response predictionZain Khurshid, Hojjat Ahmadzadehfar, Florian C Gaertner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 17, 2015
Imaging large vessel vasculitis with fully integrated PET/MRI: a pilot studyIngo Einspieler, Klaus Thürmel, Thomas Pyka, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 31, 2019
<sup>68</sup>Ga-PSMA PET/CT for monitoring response to <sup>177</sup>Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancerAlexander Heinzel, Dima Boghos, Felix M Mottaghy, et al.
Plos One|June 1, 2013
Alpha-particle emitting 213Bi-anti-EGFR immunoconjugates eradicate tumor cells independent of oxygenationChristian Wulbrand, Christof Seidl, Florian C Gaertner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 7, 2008
Local motion correction for lung tumours in PET/CT--first resultsRalph A Bundschuh, Axel Martínez-Möller, Markus Essler, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 25, 2017
The impact of repeated cycles of radioligand therapy using [<sup>177</sup>Lu]Lu-PSMA-617 on renal function in patients with hormone refractory metastatic prostate cancerAnna Yordanova, Anja Becker, Elisabeth Eppard, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 3, 2017
Improving quality of life in patients with pancreatic neuroendocrine tumor following peptide receptor radionuclide therapy assessed by EORTC QLQ-C30Milka Marinova, Martin Mücke, Lukas Mahlberg, et al.
Investigational New Drugs|June 6, 2020
Integrative analysis of key candidate genes and signaling pathways in autoimmune thyroid dysfunction related to anti-CTLA-4 therapy by bioinformaticsYing Zhang, Francesca Garofano, Xiaolong Wu, et al.
Pageof 21

Showing results (71-80 of 208) with videos related to

Sort By:
Pageof 21
The Prostate|March 20, 2024
Key learnings from concordant systematic biopsies in prostate-specific membrane antigen positron emission tomography/computed tomography-guided prostate biopsies: Enhancing targeting accuracyThomas Büttner, Florian Gärtner, Markus Essler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
Preclinical evaluation of the alpha-particle generator nuclide 225Ac for somatostatin receptor radiotherapy of neuroendocrine tumorsMatthias Miederer, Gjermund Henriksen, Andrea Alke, et al.
Oncotarget|October 4, 2018
Role of textural heterogeneity parameters in patient selection for 177Lu-PSMA therapy via response predictionZain Khurshid, Hojjat Ahmadzadehfar, Florian C Gaertner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 17, 2015
Imaging large vessel vasculitis with fully integrated PET/MRI: a pilot studyIngo Einspieler, Klaus Thürmel, Thomas Pyka, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 31, 2019
<sup>68</sup>Ga-PSMA PET/CT for monitoring response to <sup>177</sup>Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancerAlexander Heinzel, Dima Boghos, Felix M Mottaghy, et al.
Plos One|June 1, 2013
Alpha-particle emitting 213Bi-anti-EGFR immunoconjugates eradicate tumor cells independent of oxygenationChristian Wulbrand, Christof Seidl, Florian C Gaertner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 7, 2008
Local motion correction for lung tumours in PET/CT--first resultsRalph A Bundschuh, Axel Martínez-Möller, Markus Essler, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 25, 2017
The impact of repeated cycles of radioligand therapy using [<sup>177</sup>Lu]Lu-PSMA-617 on renal function in patients with hormone refractory metastatic prostate cancerAnna Yordanova, Anja Becker, Elisabeth Eppard, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 3, 2017
Improving quality of life in patients with pancreatic neuroendocrine tumor following peptide receptor radionuclide therapy assessed by EORTC QLQ-C30Milka Marinova, Martin Mücke, Lukas Mahlberg, et al.
Investigational New Drugs|June 6, 2020
Integrative analysis of key candidate genes and signaling pathways in autoimmune thyroid dysfunction related to anti-CTLA-4 therapy by bioinformaticsYing Zhang, Francesca Garofano, Xiaolong Wu, et al.
Pageof 21